MCL1 and liver cancer: For example, imperatorin has been reported as a potential chemotherapeutic agent in human larynx cancer.[24] Another study showed that imperatorin could suppress drug‐resistant liver cancer through inducing Mcl‐1 degradation to cooperatively trigger Bax translocation and Bak activation.[12] However, most of the studies focus on the function of imperatorin in chemoresistance, we provide the first evidence suggesting the potential of imperatorin in suppressing tumor invasion and metastasis.